SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells

Terry W. Moody, Jessica Chiles, Marchessini Casibang, Elizabeth Moody, Daniel Chan, Thomas P Davis

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Neurotensin (NT) is an autocrine growth factor for some small cell lung cancer (SCLC) cells. In this communication, the effects of a non-peptide NT receptor antagonist, SR48692, were investigated using SCLC cells. 3H-SR48692 bound with high affinity (IC50 = 20 nM) to NCI-H209 cells. Also, NT and SR48692 inhibited specific 125I-NT binding with high affinity (IC50 values of 2 and 200 nM). In contrast, the NT2 receptor agonist, levocabastine, had little effect on specific 125I-NT binding, second messenger production and proliferation using NCI-H209 cells. SR48692 (5 μM) antagonized the ability of NT (10 nM) to cause elevated cytosolic Ca2+ in Fura-2 AM loaded NCI-H209 cells. SR48692 antagonized the ability of NT to cause elevation of c-fos mRNA in these cells. Using a MTT proliferation assay, SR48692 inhibited NCI-H209 and H345 proliferation in a concentration-dependent manner. Using a clonogenic assay, 1 μM SR48692, reduced NCI-H209 colony number. Also, SR48692 (0.4 mg/kg per day) inhibited NCI-H209 xenograft proliferation in nude mice. These results suggest that SR48692 is a NT1 receptor antagonist which inhibits SCLC growth.

Original languageEnglish (US)
Pages (from-to)109-115
Number of pages7
JournalPeptides
Volume22
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Neurotensin Receptors
Small Cell Lung Carcinoma
Neurotensin
Cells
Growth
levocabastine
Inhibitory Concentration 50
Assays
SR 48692
Fura-2
Second Messenger Systems
Heterografts
Nude Mice
Intercellular Signaling Peptides and Proteins

Keywords

  • C-fos mRNA
  • Cytosolic Ca
  • Lung cancer
  • Proliferation
  • Receptor binding
  • SR48692

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells. / Moody, Terry W.; Chiles, Jessica; Casibang, Marchessini; Moody, Elizabeth; Chan, Daniel; Davis, Thomas P.

In: Peptides, Vol. 22, No. 1, 2001, p. 109-115.

Research output: Contribution to journalArticle

Moody, Terry W. ; Chiles, Jessica ; Casibang, Marchessini ; Moody, Elizabeth ; Chan, Daniel ; Davis, Thomas P. / SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells. In: Peptides. 2001 ; Vol. 22, No. 1. pp. 109-115.
@article{6546eab383cb4dec8df88b06450ded9c,
title = "SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells",
abstract = "Neurotensin (NT) is an autocrine growth factor for some small cell lung cancer (SCLC) cells. In this communication, the effects of a non-peptide NT receptor antagonist, SR48692, were investigated using SCLC cells. 3H-SR48692 bound with high affinity (IC50 = 20 nM) to NCI-H209 cells. Also, NT and SR48692 inhibited specific 125I-NT binding with high affinity (IC50 values of 2 and 200 nM). In contrast, the NT2 receptor agonist, levocabastine, had little effect on specific 125I-NT binding, second messenger production and proliferation using NCI-H209 cells. SR48692 (5 μM) antagonized the ability of NT (10 nM) to cause elevated cytosolic Ca2+ in Fura-2 AM loaded NCI-H209 cells. SR48692 antagonized the ability of NT to cause elevation of c-fos mRNA in these cells. Using a MTT proliferation assay, SR48692 inhibited NCI-H209 and H345 proliferation in a concentration-dependent manner. Using a clonogenic assay, 1 μM SR48692, reduced NCI-H209 colony number. Also, SR48692 (0.4 mg/kg per day) inhibited NCI-H209 xenograft proliferation in nude mice. These results suggest that SR48692 is a NT1 receptor antagonist which inhibits SCLC growth.",
keywords = "C-fos mRNA, Cytosolic Ca, Lung cancer, Proliferation, Receptor binding, SR48692",
author = "Moody, {Terry W.} and Jessica Chiles and Marchessini Casibang and Elizabeth Moody and Daniel Chan and Davis, {Thomas P}",
year = "2001",
doi = "10.1016/S0196-9781(00)00362-4",
language = "English (US)",
volume = "22",
pages = "109--115",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells

AU - Moody, Terry W.

AU - Chiles, Jessica

AU - Casibang, Marchessini

AU - Moody, Elizabeth

AU - Chan, Daniel

AU - Davis, Thomas P

PY - 2001

Y1 - 2001

N2 - Neurotensin (NT) is an autocrine growth factor for some small cell lung cancer (SCLC) cells. In this communication, the effects of a non-peptide NT receptor antagonist, SR48692, were investigated using SCLC cells. 3H-SR48692 bound with high affinity (IC50 = 20 nM) to NCI-H209 cells. Also, NT and SR48692 inhibited specific 125I-NT binding with high affinity (IC50 values of 2 and 200 nM). In contrast, the NT2 receptor agonist, levocabastine, had little effect on specific 125I-NT binding, second messenger production and proliferation using NCI-H209 cells. SR48692 (5 μM) antagonized the ability of NT (10 nM) to cause elevated cytosolic Ca2+ in Fura-2 AM loaded NCI-H209 cells. SR48692 antagonized the ability of NT to cause elevation of c-fos mRNA in these cells. Using a MTT proliferation assay, SR48692 inhibited NCI-H209 and H345 proliferation in a concentration-dependent manner. Using a clonogenic assay, 1 μM SR48692, reduced NCI-H209 colony number. Also, SR48692 (0.4 mg/kg per day) inhibited NCI-H209 xenograft proliferation in nude mice. These results suggest that SR48692 is a NT1 receptor antagonist which inhibits SCLC growth.

AB - Neurotensin (NT) is an autocrine growth factor for some small cell lung cancer (SCLC) cells. In this communication, the effects of a non-peptide NT receptor antagonist, SR48692, were investigated using SCLC cells. 3H-SR48692 bound with high affinity (IC50 = 20 nM) to NCI-H209 cells. Also, NT and SR48692 inhibited specific 125I-NT binding with high affinity (IC50 values of 2 and 200 nM). In contrast, the NT2 receptor agonist, levocabastine, had little effect on specific 125I-NT binding, second messenger production and proliferation using NCI-H209 cells. SR48692 (5 μM) antagonized the ability of NT (10 nM) to cause elevated cytosolic Ca2+ in Fura-2 AM loaded NCI-H209 cells. SR48692 antagonized the ability of NT to cause elevation of c-fos mRNA in these cells. Using a MTT proliferation assay, SR48692 inhibited NCI-H209 and H345 proliferation in a concentration-dependent manner. Using a clonogenic assay, 1 μM SR48692, reduced NCI-H209 colony number. Also, SR48692 (0.4 mg/kg per day) inhibited NCI-H209 xenograft proliferation in nude mice. These results suggest that SR48692 is a NT1 receptor antagonist which inhibits SCLC growth.

KW - C-fos mRNA

KW - Cytosolic Ca

KW - Lung cancer

KW - Proliferation

KW - Receptor binding

KW - SR48692

UR - http://www.scopus.com/inward/record.url?scp=0035130471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035130471&partnerID=8YFLogxK

U2 - 10.1016/S0196-9781(00)00362-4

DO - 10.1016/S0196-9781(00)00362-4

M3 - Article

C2 - 11179604

AN - SCOPUS:0035130471

VL - 22

SP - 109

EP - 115

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 1

ER -